TESTOSTERONE PROPIONATE

PRODUCT IDENTIFICATION
CAS NO. 57-85-2

TESTOSTERONE PROPIONATE
EINECS NO. 200-351-1
FORMULA C22H32O3
MOL WT. 344.49

H.S. CODE

TOXICITY

SYNONYMS Testosteroni propionas;
17-(1-oxopropoxy)-(17beta)-androst-4-en-3-one; 3-Oxo-4-androsten-17beta-yl propionate; delta4-androstene-17b-propionate-3-one; testosterone-17beta-propionate; 17beta-Propionyloxy-4-androsten-3-one; 17beta-Hydroxy-4-androsten-3-one 17-propionate; 4-Androsten-17beta-ol-3-one 17-propionate;
DERIVATION

 

CLASSIFICATION

  

PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL STATE white to off-white crystalline powder
MELTING POINT 118 - 121 C
BOILING POINT

SPECIFIC GRAVITY

SOLUBILITY IN WATER Insoluble
pH
VAPOR DENSITY

AUTOIGNITION

NFPA RATINGS

 Health: 2 Flammability: 0 Reactivity: 0

REFRACTIVE INDEX

 
FLASH POINT

 
STABILITY

Stable under ordinary conditions

APPLICATIONS
Testosterone is the major androgenic hormone that is responsible for the growth and development of masculine characteristics. It is produced in the Leydig cells (interstitial cells) of the testes. it regulates gonadotropic secretion and wolffian duct differentiation (formation of the epididymis, vas deferens, and seminal vesicle), and stimulates skeletal muscle. It is also responsible for other male characteristics and spermatogenesis after its conversion to dihydrotestosterone by 5alpha-reductase in peripheral tissue. Testosterone is converted to dihydrotestosterone in the target tissues where it appears to mediate many of the biological actions of testosterone. In addition, testosterone possesses protein anabolic properties, manifested by retention of nitrogen, calcium, phosphorus, and potassium, and is important in maintaining muscle mass and bone tissue in the adult male. It is also converted by aromatization to estradiol in peripheral tissue. It has been synthesized for replacement therapy, in the form of various esters having prolonged duration of effects, in treating male hypogonadism, cryptorchidism, frigidity, inoperable female breast cancer, oligospermia, to suppress lactation, and as an anabolic agent. Esters administered by subcutaneous, intramuscular injection, buccally or intramuscularly include;

· Cloxotestosterone (CAS RN: 53608-96-1)
· Ethisterone (Ethynyl testosterone, CAS RN: 434-03-7)
· Mestanolone (CAS RN: 521-11-9)
· 17alpha-Methyltestosterone (CAS RN: 58-18-4)
· Norethindrone (CAS RN: 68-22-4)
· Normethisterone (CAS RN: 514-61-4)
· Oxymetholone (CAS RN: 434-07-1)
· Silandrone (Testosterone trimethylsilyl ether, CAS RN: 5055-42-5)
· Testosterone Acetate (CAS RN: 1045-69-8)
· Testosterone Phenylpropionate (CAS RN: 1255-49-8)
· Testosterone Benzoate (CAS RN: 2088-71-3)
· Testosterone heptanoate (CAS RN: 315-37-7)
· Testosterone phenylacetate (CAS RN: 5704-03-0)
· Testosterone propionate (CAS RN: 57-85-2)
· Testosterone cypionate (CAS RN: 58-20-8)
· Testosterone ketolaurate (CAS RN: 5874-98-6)
· Testosterone Undecanoate
· Testosterone Glucuronide
· Testosterone Hemisuccinate
SALES SPECIFICATION

APPEARANCE

 white to off-white crystalline powder

ASSAY
97.0 - 103.0%

MELTING POINT

118 - 121 C

OPTICAL ROTATION

+83° ~ +90°

LOSS ON DRYING

0.5% max
TRANSPORTATION
PACKING

5kgs in can
HAZARD CLASS
UN NO.
OTHER INFORMATION
Hazard Symbols: T, Risk Phrases: 45-22-63, Safety Phrases: 53-36/37-45